Similarly, the case-control analysis showed that the CYP2B6*6 allele frequency was significantly higher in the GMD case group than in the control group implying the link between a defective enzyme function with the risk of DM in long-term EFV-based cART. The gene discussed is CYP2B6; the disease is diabetes mellitus.